KL Report

Srinagar: Dr Khalid Shah, presently working as Associate  professor in Harvard School of Medicine, USA will deliver lecture at Sher-e-Kashmir Institute of Medical Sciences (SKIMS) Soura on June 25 on ‘Stem Cell based Therapies for Cancer: Promising Future in a Tactical Feud.’

Dr Khalid Shah’s therapy to treat brain tumour has now been acknowledged as one of the 12 technologies that will impact the patient care in near future.

Director SKIMS Dr Showkat Zargar said SKIMS welcomed Dr Shah who is a well- known medical expert and comes from prestigious medical instate. “The lecture and deliberations will benefit both faculty and students at large. SKIMS is happy to host renowned researchers and medical experts who have a great contribution in the field across globe to share their experiences and perspectives on the Subj ect back home,” he added.

Dr Shah is the Director of the Stem Cell Therapeutics and Imaging program at and also heads the Molecular Neurotherapy and Imaging Laboratory at Massachusetts General Hospital in Boston. He is also a Principal Faculty at Harvard Stem Cell Institute in Boston. ln recent years, Dr Shah and his team have done some pioneering work on developing therapeutic stem cells for cancer, particularly brain tumours. These studies have been published in a number of very high impact journals like Nature Neuroscience, PNAS, Stem Cells and Lancet Oncology, validating the use of therapeutic stem cells alone and in combination with clinically approved drugs for cancer therapy.

Besides many publications to his credit Dr. Shah is also recipient of many honors and awards which include Young Mentor award from Harvard Medical School, Young Investigator award from Alliance for Cancer Gene Therapy (ACGT), Research Fellow award from American Cancer Society (ACS) and also a number of translational grant awards from American Brain Tumour Association (ABTA), Goldhirsh Foundation, James S. McDonnell Foundation and National Institutes of Health (NIH).


Please enter your comment!
Please enter your name here